Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

BACKGROUND: Pemetrexed, a new and novel agent for primary central nervous system lymphomas (PCNSLs), has shown to be efficient as a savage therapy for recurrent PCNSLs. However, more studies are needed. A prospective study was performed on 17 recurrent PCNSL patients with pemetrexed at Shandong Tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yi, Wang, Yong, Han, Shaolong, Xing, Bo, Li, Hong, Zhu, Yufang, Zhou, Shizhen, Wang, Xiuhua, Xu, Jun, Tao, Rongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440074/
https://www.ncbi.nlm.nih.gov/pubmed/28553124
http://dx.doi.org/10.2147/OTT.S134684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440074/
https://www.ncbi.nlm.nih.gov/pubmed/28553124
http://dx.doi.org/10.2147/OTT.S134684

Ejemplares similares